Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference

Rhea-AI Summary

Shockwave Medical (NASDAQ: SWAV) is set to participate in the Piper Sandler 34th Annual Virtual Healthcare Conference from November 29 to December 1, 2022. The company's management will host a live fireside chat on November 30, 2022, at 9:30 a.m. Eastern Time. Interested parties can access the live and archived webcast via the company's Investors' section. Shockwave focuses on advancing the treatment of calcified cardiovascular disease through its Intravascular Lithotripsy (IVL) technology, aiming to enhance patient outcomes.

News Market Reaction – SWAV

+3.88%

+3.88% Session move

In the trading session that priced this news, SWAV gained 3.88%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SANTA CLARA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the company will be participating in the Piper Sandler 34th Annual Virtual Healthcare Conference, scheduled to be held from November 29 to December 1, 2022.

Shockwave management is scheduled for a live fireside chat on Wednesday, November 30, 2022, at 9:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at: https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.

Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
dkaster@shockwavemedical.com

FAQ

When is Shockwave Medical participating in the Piper Sandler Healthcare Conference?

Shockwave Medical will participate in the Piper Sandler 34th Annual Virtual Healthcare Conference from November 29 to December 1, 2022.

What time is Shockwave Medical's fireside chat during the conference?

The fireside chat is scheduled for November 30, 2022, at 9:30 a.m. Eastern Time.

How can I access the webcast of Shockwave Medical's conference presentation?

You can access the live and archived webcast on the Investors' section of Shockwave Medical's website.

What is Shockwave Medical's focus in treating cardiovascular disease?

Shockwave Medical focuses on developing products to treat calcified cardiovascular disease using a technology called Intravascular Lithotripsy (IVL).

What is Intravascular Lithotripsy (IVL)?

IVL is a minimally invasive procedure developed by Shockwave Medical that uses sonic pressure waves to treat calcified plaque in cardiovascular disease.